Syneos Health Identifies Important Drivers of Change Expected to Disrupt Healthcare
Shared Commitment to Change, New Prescriber Realities, Model Evolution and Engagement Transformation Expected to be Critical DriversMORRISVILLE, N.C., Feb. 11,...
Year: 2021
Prothena Reports Fourth Quarter and Full Year 2020 Financial Results, and Provides Financial Guidance and R&D Update
Net cash used in operating and investing activities was $19.1 million in the fourth quarter and $80.6 million for the...
Zogenix to Release Fourth Quarter and Full-Year 2020 Financial Results and Host Conference Call and Webcast on February 25
EMERYVILLE, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company developing rare disease therapies, today...
VYNE Therapeutics Announces Reverse Stock Split
BRIDGEWATER, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its...
Holy Name Medical Center Launches One-Stick Hospitalization as New Inpatient Standard of Care
First in New Jersey to standardize on needle-free blood collection procedure, Holy Name builds on its reputation as a technology...
Adaptimmune to Report Fourth Quarter/ Full Year 2020 Financial Results and Business Updates on Thursday, February 25, 2021
PHILADELPHIA and OXFORDSHIRE, United Kingdom, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy...
BioDelivery Sciences CFO Terry Coelho Promoted to Executive Vice President
Brings Track Record of Success to Expanded RoleRALEIGH, N.C., Feb. 11, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI),...
Inspire Medical Systems, Inc. to Present at the 10th Annual SVB Leerink Global Healthcare Conference
MINNEAPOLIS, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on...
Biogen Announces the Expiration Date Results of Its Private Exchange Offer
CAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced the expiration date results of...
X4 Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host a Conference Call and Webcast on March 4, 2021
BOSTON, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development...
WellDyne Partners with Scipher Medicine to Improve Patient Outcomes and Lower Costs for Rheumatoid Arthritis Care
New PrismRA® blood test enables providers to identify optimal approach to rheumatoid arthritis treatmentWALTHAM, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE)...
aTyr Pharma Announces New tRNA Synthetase Discovery Programs
Advancement of selected AARS and DARS fragments primarily targeting cancer Programs will accelerate discoveries initially focusing on natural killer (NK)...
Intercept to Announce Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and...
electroCore Announces Completion of Enrollment in SAVIOR-1 Study of Non-Invasive Vagus Nerve Stimulation (nVNS) in COVID-19 Patients Exhibiting Respiratory Symptoms
ROCKAWAY, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the...
Cidara Therapeutics to Present New Data for Rezafungin and Influenza AVCs at the 21st ICHS Symposium
SAN DIEGO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed...
Aleafia Health Launches Sunday Market™ House of Brands
The Sunday Market house of brands Aleafia Health Inc. TORONTO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX:...
Neuronetics Announces Strategic Leadership Promotions to Support Future Growth
Elevated roles announced for executive team members Steve Furlong, Greg Harper and Kara ThorntonMALVERN, Pa., Feb. 11, 2021 (GLOBE NEWSWIRE)...
Antios Therapeutics Appoints Patrick T. Higgins to Board of Directors
Former biopharmaceutical executive has been at the forefront of developing treatments for infectious diseases of the liver including HBV and...
Genocea Provides Fourth Quarter 2020 Corporate Update
GEN-011 and GEN-009 clinical trials continue to advance ATLASTMstimulatory antigen and inhibitory antigen (InhibigenTM) identification profiled in Cancer Discovery Announcing...
InflaRx Announces Presentation of New C5a and Vilobelimab (IFX-1) Data from Phase IIB SHINE Study at the 2021 Virtual European Hidradenitis Suppurativa Foundation Conference
Significantly elevated baseline C5a levels occur in hidradenitis suppurativa (HS) patientsVilobelimab dose-dependently suppresses C5a levels over time accompanied by the...